Goldman Sachs Talks Pfizer's Acquisition Deal Of Medivation

By: via Benzinga
Pfizer Inc. (NYSE: PFE) finalized a deal to acquire Medivation Inc (NASDAQ: MDVN) for $14 billion Monday morning. Goldman Sachs’ ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.